Oscar Health (NYSE:OSCR) Trading Down 2.7%

Shares of Oscar Health, Inc. (NYSE:OSCR) traded down 2.7% on Wednesday . The company traded as low as $16.75 and last traded at $16.80. 113,885 shares were traded during mid-day trading, a decline of 97% from the average session volume of 3,275,455 shares. The stock had previously closed at $17.26.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on OSCR. Robert W. Baird began coverage on shares of Oscar Health in a research note on Thursday, May 30th. They set an “outperform” rating and a $28.00 target price on the stock. The Goldman Sachs Group upped their target price on Oscar Health from $16.00 to $21.00 and gave the stock a “neutral” rating in a report on Thursday, May 9th. Baird R W raised Oscar Health to a “strong-buy” rating in a research note on Thursday, May 30th. Wells Fargo & Company raised their price objective on shares of Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a report on Wednesday, June 12th. Finally, Bank of America reissued a “neutral” rating and set a $21.00 target price (down from $25.00) on shares of Oscar Health in a report on Thursday, May 30th. Three investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $21.79.

Oscar Health Stock Down 3.0 %

The stock has a 50-day moving average of $17.15 and a 200 day moving average of $17.13. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.26. The company has a market capitalization of $3.97 billion, a PE ratio of -43.15, a P/E/G ratio of 36.05 and a beta of 1.61.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.16 by $0.04. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. The business had revenue of $2.20 billion for the quarter, compared to analyst estimates of $2.13 billion. During the same quarter in the previous year, the firm posted ($0.07) earnings per share. The company’s revenue for the quarter was up 44.6% on a year-over-year basis. Sell-side analysts anticipate that Oscar Health, Inc. will post 0.01 EPS for the current year.

Insider Activity

In other Oscar Health news, CAO Victoria Baltrus sold 7,674 shares of the stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $19.46, for a total transaction of $149,336.04. Following the sale, the chief accounting officer now owns 127,754 shares in the company, valued at $2,486,092.84. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, CAO Victoria Baltrus sold 7,674 shares of the firm’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $19.46, for a total value of $149,336.04. Following the completion of the transaction, the chief accounting officer now directly owns 127,754 shares in the company, valued at $2,486,092.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Alessandrea C. Quane sold 25,550 shares of the company’s stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $19.46, for a total transaction of $497,203.00. Following the sale, the executive vice president now directly owns 237,347 shares in the company, valued at approximately $4,618,772.62. The disclosure for this sale can be found here. Insiders have sold a total of 81,655 shares of company stock valued at $1,589,006 over the last quarter. Company insiders own 25.11% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Federated Hermes Inc. increased its stake in Oscar Health by 1.9% in the fourth quarter. Federated Hermes Inc. now owns 295,687 shares of the company’s stock valued at $2,706,000 after acquiring an additional 5,588 shares during the last quarter. Handelsbanken Fonder AB purchased a new position in shares of Oscar Health during the 4th quarter valued at about $110,000. New York State Common Retirement Fund lifted its position in Oscar Health by 3.8% in the 4th quarter. New York State Common Retirement Fund now owns 64,856 shares of the company’s stock worth $593,000 after buying an additional 2,394 shares during the last quarter. Victory Capital Management Inc. boosted its stake in Oscar Health by 37.7% in the fourth quarter. Victory Capital Management Inc. now owns 18,852 shares of the company’s stock worth $172,000 after buying an additional 5,159 shares in the last quarter. Finally, National Bank of Canada FI purchased a new position in shares of Oscar Health during the fourth quarter worth approximately $1,071,000. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.